Consequently, both PML and SUMO can act as key upstream regulators of p53, particularly in stress settings, and this PML/p53 axis is emerging as a critical mediator of cellular responses to oxidation, hypoxia, DNA damage and nutrient stress, as well as of senescence and tumor suppression during oncogenic assault [64,65]. The gene discussed is TP53; the disease is neoplasm.